Henrik Trygg/mediabank.visitstockholm.com

Mitochondria in Human Disease


Welcome to the Journal of Internal Medicine Symposium: Mitochondria in Human Disease. The field of mitochondrial research is advancing fast, and world-leading experts in the area will update us on their most recent discoveries.

The meeting will take place at the modern conference facility Vår Gård located in the beautiful natural scenery of the Stockholm archipelago. A perfect site for immersing ourselves in mitochondrial research for three days.

Thanks to sponsorship by the Journal of Internal Medicine, we offer an exclusive full conference package including housing, meals, and social activities for just 1500 SEK (142 €). However, to ensure a high level of engagement and interaction, we only have a limited number of participants. We expect the symposium will fill up fast, so register now to ensure your spot.

Mitochondrial dysfunction has a huge impact on human disease. The group of primary mitochondrial disorders is one of the most common forms of inherited disease in humans. Furthermore, mitochondrial dysfunction is secondarily involved in a wide range of common age-associated disorders, such as diabetes mellitus type 2, heart failure and various forms of neurodegeneration, as well as in the naturally occurring ageing process. The recent breakthrough in massive parallel DNA sequencing and other -omics approaches has led the discovery of many new gene defects causing primary mitochondrial disorders, which has benefitted patient diagnosis and prenatal counselling. Furthermore, many of the discovered genes have provided profound insights into the molecular regulation of mtDNA gene expression and oxidative phosphorylation.

Remarkably, also our understanding of the architecture of mitochondria has been revolutionized during recent years as biochemical and genetic methods have been used in combination with novel powerful ways of imaging mitochondria, as exemplified by cryo-electron microscopy, electron cryo-tomography and superresolution microscopy. These important advances in many different areas of mitochondrial biology has led to the development of novel principles for treatment of mitochondrial disorders. Importantly, manipulation of mitochondrial function may also provide novel avenues for treatment of common age-associated diseases as mitochondrial dysfunction often is an important secondary event when these diseases progress. The aim of the conference sponsored by Journal of Internal Medicine is to bring together scientists and clinicians to discuss how these recent breakthroughs impact our understanding of mitochondrial biology and disease.

 Welcome to the Journal of Internal Medicine Symposium:


September 16-18, 2019, Stockholm Sweden


Time left








Hosted by

Important dates

Abstract submission dead-line May 31

Notification June 10 

Deadline registration for the Symposium June 14

Professional Conference Organizer

For general information, kindly contact:

Akademikonferens +46 18 67 15 33 or the switchboard +46 18 67 10 03

For scientific content and abstracts, kindly contact: Virpi.Tohonen@ki.se